Handcrafted Pe Anti-human Cd305 Recombinant Enjoy 90% Off [BHrx8JGR]
PE Anti-Human CD305 Recombinant Antibody The PE Anti-Human CD305 Recombinant Antibody is a powerful tool for researchers studying the immune system. This recombinant antibody offers high specificity and sensitivity, making it ideal for various immuno
Secure Shopping
100% Safe Guarantee
Free Shipping
On orders over $30
Money-Back
30-Day Guarantee
Handcrafted Pe Anti-human Cd305 Recombinant Enjoy 90% Off [BHrx8JGR]
PE Anti-Human CD305 Recombinant Antibody
The PE Anti-Human CD305 Recombinant Antibody is a powerful tool for researchers studying the immune system. This recombinant antibody offers high specificity and sensitivity, making it ideal for various immunological applications. With its PE conjugation, this antibody is perfect for flow cytometry, allowing for the detection and analysis of CD305-expressing cells with exceptional clarity.Product Specifications and Benefits
This antibody is designed to recognize and bind to human CD305, also known as LAIR-1, a 40 kD type I transmembrane glycoprotein. LAIR-1 is expressed on a wide range of immune cells, including NK cells, T cells, B cells, and dendritic cells, making it a versatile target for immunological research. Key features of this antibody include:- Reactivity: Human
- Format: PE conjugated
- Host: Mouse
- Isotype: IgG1, κ
- Applications: Flow Cytometry
Applications and Target Audience
The PE Anti-Human CD305 Recombinant Antibody is ideal for researchers investigating immune responses, cell signaling, and the role of LAIR-1 in various diseases. Its applications include:- Flow Cytometry: Analysis of CD305 expression on immune cells
- Immunophenotyping: Characterization of immune cell populations
- Functional Assays: Studying the role of LAIR-1 in immune regulation
What Our Customers Say
Absolutely no complaints!
This is an impressive and solid gadget.
- Alun Z..
Absolutely no complaints!
An outstanding tool. Very useful.
- Lleu Q..
Absolutely no complaints!
A great purchase. The quality is evident.
- Lysandra W..